Macquarie Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,908
| Closed | -$1.51M | – | 1670 |
|
|
2025
Q1 | $1.51M | Sell |
44,908
-303
| -0.7% | -$10.2K | ﹤0.01% | 1314 |
|
|
2024
Q4 | $2.31M | Sell |
45,211
-401
| -0.9% | -$20.5K | ﹤0.01% | 1155 |
|
|
2024
Q3 | $2.33M | Buy |
+45,612
| New | +$2.33M | ﹤0.01% | 1183 |
|
|
2022
Q4 | – | Sell |
-3,138
| Closed | -$62K | – | 1894 |
|
|
2022
Q3 | $62K | Hold |
3,138
| – | – | ﹤0.01% | 1886 |
|
|
2022
Q2 | $59K | Hold |
3,138
| – | – | ﹤0.01% | 2007 |
|
|
2022
Q1 | $69 | Buy |
+3,138
| New | +$69 | ﹤0.01% | 2037 |
|